Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Vericel Corp (VCEL)
|
Add to portfolio |
|
|
|
| Price: |
$56.60
| | Metrics |
| OS: |
47.6
|
M
| |
-9
|
% ROE
|
| Market cap: |
$2.69
|
B
| |
-11
|
% ROIC
|
|
Net cash:
|
$139
|
M
| |
$2.93
|
per share
|
|
EV:
|
$2.55
|
B
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($13.7)
|
M
| |
|
|
|
EBIT
|
($18.0)
|
M
| |
|
|
| EPS |
($0.36)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Revenues | 164.4 | 156.2 | 124.2 | 117.9 | 90.9 | 63.9 | 54.4 | 51.2 |
| Revenue growth | 5.2% | 25.8% | 5.4% | 29.7% | 42.1% | 17.5% | 6.3% | 77.7% |
| Cost of goods sold | 54.6 | 50.2 | 40.0 | 37.6 | 32.2 | 30.4 | 28.3 | 26.5 |
| Gross profit | 109.8 | 106.0 | 84.2 | 80.3 | 58.7 | 33.6 | 26.1 | 24.7 |
| Gross margin | 66.8% | 67.9% | 67.8% | 68.1% | 64.6% | 52.5% | 47.9% | 48.3% |
| Selling, general and administrative | 106.9 | 97.6 | 68.8 | 61.1 | 49.0 | 35.6 | 27.4 | 22.5 |
| Research and development | 19.9 | 16.3 | 13.0 | 30.4 | 13.6 | 12.9 | 15.3 | 18.9 |
| EBIT | -17.1 | -7.9 | 2.4 | -11.3 | -3.9 | -15.0 | -16.6 | -16.7 |
| EBIT margin | -10.4% | -5.0% | 1.9% | -9.5% | -4.3% | -23.4% | -30.5% | -32.6% |
| Pre-tax income | -16.0 | -7.6 | 3.0 | -9.7 | -8.1 | -17.3 | -19.6 | -16.3 |
| Income taxes | 0.7 | -0.1 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | | 1.5% | 5.9% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -16.7 | -7.5 | 2.9 | -9.7 | -8.1 | -17.3 | -19.6 | -16.3 |
| Net margin | -10.2% | -4.8% | 2.3% | -8.2% | -9.0% | -27.0% | -36.0% | -31.9% |
| |
| Diluted EPS | ($0.35) | ($0.16) | $0.06 | ($0.22) | ($0.20) | ($0.52) | ($0.85) | ($0.69) |
| Shares outstanding (diluted) | 47.1 | 46.5 | 47.3 | 44.2 | 40.2 | 33.4 | 23.1 | 23.8 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|